Official Title: Molecular Assessment for Gastro-Esophageal Cancer
Status: RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MAGEC
Brief Summary: The goal of this minimally invasive interventional study is to learn if oncometabolic biomarkers detected in the exhaled breath and blood can identify early-stage gastro-oesophageal cancer in patient at risk for gastro-oesophageal cancer
The main questions this study aims to answer
Are oncometabolites proficient and reproducible enough to function as diagnostic biomarkers Can these biomarkers identify early-stage gastro-esophageal cancer Researchers will compare participants with gastro-oesophageal cancer to healthy controls and participants with Barretts esophagus to detect meaningful differences between the groups
Participants will provide a breath and blood sample during their routine standard of care visits